|
Real-time Estimate
Cboe BZX
14:14:55 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 81.87 USD | +4.57% |
|
-0.16% | +22.31% |
| 10-05 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 09-20 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 525M | - | - | - | - | - |
| 74.31B | |||||
| 56.95B | |||||
| 48.3B | |||||
| 44.51B | - | - | - | - | - |
| 43.8B |
Select your edition
All financial news and data tailored to specific country editions
